Drawing for THE POWER WITHIN

USPTO serial 85968231

THE POWER WITHIN

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
VOHRA, SANJEEV KUMAR
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with THE POWER WITHIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marilyn F. Kelly

MARILYN F. KELLY BRISTOL-MYERS SQUIBB COMPANYPO BOX 4000PRINCETON, NJ 08543-4000UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodiesACTIVE
016Printed matter, namely, advertising and promotional information materials in the nature of newsletters, pamphlets, leaflets and brochures in the field of health care, cancer and pharmaceuticalsACTIVE
035Public relations; Promotional services, namely, promoting public awareness with respect to the treatment and prevention of diseasesACTIVE
044Health care services, namely, providing information to physicians, health care professionals and patients on the topic of health issues and health awareness; Providing medical and pharmaceutical information in the field of oncology and pharmaceutical preparations for the prevention or treatment of cancer through the Internet. Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticalsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 21, 2015MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 21, 2015ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 17, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 23, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 23, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 3, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 15, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 13, 2014ALIEASSIGNED TO LIE
Oct 28, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 21, 2014GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 21, 2014GNSLLETTER OF SUSPENSION E-MAILED
Apr 21, 2014CNSLSUSPENSION LETTER WRITTEN
Mar 31, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Mar 31, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 31, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 30, 2013GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 30, 2013GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 30, 2013CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 25, 2013DOCKASSIGNED TO EXAMINER
Jul 5, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 27, 2013NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance